Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

First responders in Shelby County are staffing up for the severe weather expected to move into central Alabama. “What we’ve ...

Q4 2024 Earnings Call Transcript March 13, 2025 Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is ...

Trump isn't happy the future Air Force One 747 fleet may not be delivered before he leaves office in 2029. He'll be stuck ...

Patients with non-small cell lung cancer undergoing lobectomy or pneumonectomy whose treatment facility was in a U.S.